中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝硬化腹水诊治争议问题

谢渭芬 曾欣

引用本文:
Citation:

肝硬化腹水诊治争议问题

DOI: 10.3969/j.issn.1001-5256.2014.07.006
详细信息
  • 中图分类号: R575.2

Controversial problems in management of cirrhotic ascites

  • 摘要: 腹水是肝硬化预后不良的重要指标。近年来尽管出台了很多有关肝硬化腹水的指南和共识,但其处理中仍存在一些争议。回顾了目前肝硬化腹水处置中的难点及争议问题,如补钠和限钠的时机、利尿剂的选择、利水剂的应用价值、大量放腹水后补充白蛋白的方案、经颈静脉肝内门体分流术的指征和疗效等;并指出运用循证医学手段解决上述争议性问题,有助于提高肝硬化腹水的诊疗水平,改善患者预后。

     

  • [1]European Association for the Study of the Liver.EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J].J Hepatol, 2010, 53 (3) :397-417.
    [2]RUNYON BA, AASLD.Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012[J].Hepatology, 2013, 57 (4) :1651-1653.
    [3]MOORE KP, WONG F, GINES P, et al.The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club[J].Hepatology, 2003, 38 (1) :258-266.
    [4]REYNOLDS TB, LIEBERMAN FL, GOODMAN AR.Advantages of treatment of ascites without sodium restriction and without complete removal of excess fluid[J].Gut, 1978, 19 (6) :549-553.
    [5]GAUTHIER A, LEVY VG, QUINTON A, et al.Salt or no salt in the treatment of cirrhotic ascites:a randomised study[J].Gut, 1986, 27 (6) :705-709.
    [6]GUEVARA M, CARDENAS A, URIZ J, et al.Prognosis in patients with cirrhosis and ascites[M]//GINS P, ARROYO V, RODS J, et al.Ascites and renal dysfunction in liver disease:pathogenesis, diagnosis and treatment.Malden:BlackwellPublishers, 2005:260-270.
    [7]SERSTT, GUSTOT T, RAUTOU PE, et al.Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites[J].J Hepatol, 2012, 57 (2) :274-280.
    [8]SANTOS J, PLANAS R, PARDO A, et al.Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis.A randomized comparative study of efficacy and safety[J].J Hepatol, 2003, 39 (2) :187-192.
    [9]ANGELI P, FASOLATO S, MAZZA E, et al.Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis:results of an open randomised clinical trial[J].Gut, 2010, 59 (1) :98-104.
    [10]BERNARDI M.Optimum use of diuretics in managing ascites in patients with cirrhosis[J].Gut, 2010, 59 (1) :10-11.
    [11]WONG F, WATSON H, GERBES A, et al.Satavaptan for the management of ascites in cirrhosis:efficacy and safety across the spectrum of ascites severity[J].Gut, 2012, 61 (1) :108-116.
    [12]DAHL E, GLUUD LL, KIMER N, et al.Meta-analysis:the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia[J].Aliment Pharmacol Ther, 2012, 36 (7) :619-626.
    [13]TORRES VE, CHAPMAN AB, DEVUYST O, et al.Tolvaptan in patients with autosomal dominant polycystic kidney disease[J].N Engl J Med, 2012, 367 (25) :2407-2418.
    [14]GINES A, FERNANDEZ-ESPARRACH G, MONESCILLO A, et al.Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis[J].Gastroenterology, 1996, 111 (4) :1002-1110.
    [15]POZZI M, OSCULATI G, BOARI G, et al.Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites[J].Gastroenterology, 1994, 106 (3) :709-719.
    [16]CAMPBELL MS, BRENSINGER CM, SANYAL AJ, et al.Quality of life in refractory ascites:transjugular intrahepatic portal-systemic shunting versus medical therapy[J].Hepatology, 2005, 42 (3) :635-640.
    [17]SALERNO F, CAMMA C, ENEA M, et al.Transjugular intrahepatic portosystemic shunt for refractory ascites:a meta-analysis of individual patient data[J].Gastroenterology, 2007, 133 (3) :825-834.
    [18]MALINCHOC M, KAMATH PS, GORDON FD, et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J].Hepatology, 2000, 31 (4) :864-871.
  • 加载中
计量
  • 文章访问数:  2794
  • HTML全文浏览量:  18
  • PDF下载量:  815
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-03-31
  • 出版日期:  2014-07-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回